Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Varicella Zoster Virus Not Associated with Giant Cell Arteritis Pathogenesis

Carina Stanton  |  February 4, 2020

Zika Virus

Although varicella zoster virus may play a role in the pathogenesis of giant cell arteritis (GCA), research suggesting that reactivation of the varicella zoster virus is an infectious trigger of GCA has been difficult to replicate.1 Further, some physicians have expressed concern that treating GCA patients with antivirals based on this assumption may have negative effects on patients’ overall health. This approach may not effectively treat GCA, according to Robert Padera Jr., MD, PhD, a pathologist at Brigham and Women’s Hospital, Boston.

Dr. Padera and his rheumatologist and pathologist colleagues have sought to better understand the potential association between the varicella zoster virus and GCA development. “The field has learned much about the downstream steps in the pathogenesis of GCA, including the role of dendritic cells and inflammatory cell recruitment, but the initial activating event remains unclear,” he says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Testing for a Connection
Together, Dr. Padera and his team designed a study to detect the presence of the virus in temporal artery biopsies and ascending aortic resections that were immunostained using a combination of varicella zoster virus antibodies. The researchers identified 41 temporal artery biopsies and 47 ascending aortic resections that were positive for GCA from 2007–2017. Each test specimen was negative for varicella zoster virus by morphology and immunohistochemistry. 

An important aspect of this research involves how the test specimens reacted to the varicella zoster virus immunostain. “True staining for varicella zoster virus is strongly positive within the nucleus and cytoplasm of infected cells, with little staining of the extracellular matrix,” Dr. Padera writes in the study, published in the December 2019 issue of The Journal of Rheumatology.2

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Padera further explains the interpretation of previous similar research detecting varicella zoster virus in immunostained GCA biopsies has issues because the reported areas of virus positivity in the stain don’t conform anatomically to the outline of cells or other intrinsic tissue structures.1 Additionally, he suggests the difference in antibodies or immunohistochemical protocols used in the previous research may be a reason for discordance with the current findings. The prior study used an antibody recommended for use on Western blots and immunofluorescence on fresh frozen tissue, not on formalin-fixed, paraffin-embedded tissue. This difference may have resulted in false positive staining in that study.

“Our study results finding a lack of association between varicella zoster virus and GCA provide further evidence to research identifying similar results, including two recent studies that reached the same conclusion we did,” Dr. Padera says.3,4

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:GCAgiant cell arteritis (GCA)varicella zoster virus

Related Articles

    Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection

    March 1, 2013

    Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously

    Updates on Giant Cell Arteritis

    March 19, 2018

    SAN DIEGO—Recent research tells us more about giant cell arteritis (GCA) to help rheumatologists more accurately diagnose and effectively treat patients with this type of vasculitis. On Nov. 6 at the ACR/ARHP Annual Meeting, three experts explored the latest findings on GCA pathogenesis, diagnostic approaches, imaging modalities and growing treatment options. GCA: What’s Really Happening?…

    Atypical Giant Cell Arteritis Case Illustrates Diagnosis, Management Challenges

    Atypical Giant Cell Arteritis Case Illustrates Diagnosis, Management Challenges

    November 14, 2021

    Giant cell arteritis (GCA) is a granulomatous vasculitis of large- and medium-sized arteries, usually affecting the cranial branches of the aortic arch. It is the most common vasculitis, with the highest risk factor being age. Accurate diagnosis and prompt initiation of therapy are of great importance to prevent serious complications, with the most feared being…

    Giant Cell Arteritis Challenging to Diagnose, Manage

    March 1, 2015

    Common form of primary vasculitis difficult to identify, treat, but latest research suggests potential new therapeutic targets

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences